Shiyao Zhou

556 total citations
17 papers, 381 citations indexed

About

Shiyao Zhou is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Shiyao Zhou has authored 17 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Biomedical Engineering. Recurrent topics in Shiyao Zhou's work include Nanoplatforms for cancer theranostics (5 papers), RNA Interference and Gene Delivery (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Shiyao Zhou is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), RNA Interference and Gene Delivery (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Shiyao Zhou collaborates with scholars based in China. Shiyao Zhou's co-authors include Yuxia Luan, Qi Shang, Ningning Wang, Aixin Song, Qian Li, Yue Jiang, Jianbo Ji, Qinjie Wu, Changyang Gong and Yaxin Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Chemical Engineering Journal.

In The Last Decade

Shiyao Zhou

15 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiyao Zhou China 9 211 148 112 79 75 17 381
Yucheng Xiang China 14 130 0.6× 253 1.7× 111 1.0× 77 1.0× 84 1.1× 38 537
Shengsheng Cai China 8 315 1.5× 143 1.0× 200 1.8× 62 0.8× 56 0.7× 10 446
Zilin Guan China 10 338 1.6× 130 0.9× 137 1.2× 84 1.1× 98 1.3× 13 526
Mahsa Akbari Oryani Iran 12 129 0.6× 215 1.5× 77 0.7× 49 0.6× 101 1.3× 28 518
Linnan Yang China 8 165 0.8× 95 0.6× 118 1.1× 79 1.0× 46 0.6× 11 382
Yitian Jiang China 8 325 1.5× 133 0.9× 92 0.8× 73 0.9× 43 0.6× 9 542
Lifo Ruan China 12 258 1.2× 143 1.0× 132 1.2× 28 0.4× 40 0.5× 18 398
Congjun Xu China 9 176 0.8× 110 0.7× 60 0.5× 58 0.7× 77 1.0× 24 386
Junna Lu China 9 252 1.2× 108 0.7× 145 1.3× 57 0.7× 25 0.3× 15 411

Countries citing papers authored by Shiyao Zhou

Since Specialization
Citations

This map shows the geographic impact of Shiyao Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiyao Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiyao Zhou more than expected).

Fields of papers citing papers by Shiyao Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiyao Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiyao Zhou. The network helps show where Shiyao Zhou may publish in the future.

Co-authorship network of co-authors of Shiyao Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Shiyao Zhou. A scholar is included among the top collaborators of Shiyao Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiyao Zhou. Shiyao Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhou, Shiyao, Xinchao Li, Tao Chen, et al.. (2025). A versatile immunomodulated nanoCRISPR converter augments the susceptibility and visibility of tumors to the immune system. Proceedings of the National Academy of Sciences. 122(29). e2415100122–e2415100122.
2.
3.
4.
Zhou, Shiyao, et al.. (2024). Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment. SHILAP Revista de lepidopterología. 3(1). 19 indexed citations
5.
Zhou, Shiyao, et al.. (2024). CRISPR/Cas gene editing and delivery systems for cancer therapy. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 16(1). e1938–e1938. 6 indexed citations
6.
Zhou, Shiyao, et al.. (2024). Extract of Nanhaia speciosa J. Compton & Schrire alleviates LPS-induced acute lung injury via the NF-κB/Nrf2/AQPs pathway. Journal of Ethnopharmacology. 337(Pt 1). 118831–118831. 2 indexed citations
7.
Du, Jingxia, et al.. (2024). Pharmacological Activation of AMPK Prevents Drp1-mediated Mitochondrial Fission and Alleviates Hepatic Steatosis In vitro. Current Molecular Medicine. 24(12). 1506–1517. 4 indexed citations
8.
Liu, Xiaowei, Suleixin Yang, Li Wang, et al.. (2023). Hierarchically tumor-activated nanoCRISPR-Cas13a facilitates efficient microRNA disruption for multi-pathway-mediated tumor suppression. Theranostics. 13(9). 2774–2786. 3 indexed citations
9.
Zhou, Shiyao, Qi Shang, Jianbo Ji, & Yuxia Luan. (2021). A Nanoplatform to Amplify Apoptosis-to-Pyroptosis Immunotherapy via Immunomodulation of Myeloid-Derived Suppressor Cells. ACS Applied Materials & Interfaces. 13(40). 47407–47417. 58 indexed citations
10.
Shang, Qi, et al.. (2021). Dual cancer stem cell manipulation to enhance phototherapy against tumor progression and metastasis. Journal of Controlled Release. 340. 282–291. 17 indexed citations
11.
12.
Liu, Shuai, Xiaoying Wang, Tian-bao Huang, et al.. (2020). Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis. Annals of Palliative Medicine. 9(4). 1708–1717. 1 indexed citations
13.
Wang, Ningning, Yaxin Zhou, Xiaomeng Ren, et al.. (2020). Molecular engineering of anti-PD-L1 peptide and photosensitizer for immune checkpoint blockade photodynamic-immunotherapy. Chemical Engineering Journal. 400. 125995–125995. 49 indexed citations
14.
Zhou, Shiyao, Qi Shang, Ningning Wang, et al.. (2020). Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone. Journal of Controlled Release. 328. 617–630. 138 indexed citations
15.
Shang, Qi, Shiyao Zhou, Yue Jiang, et al.. (2020). Rational Design of a Robust Antibody-like Small-Molecule Inhibitor Nanoplatform for Enhanced Photoimmunotherapy. ACS Applied Materials & Interfaces. 12(36). 40085–40093. 38 indexed citations
16.
17.
Yang, Bin, et al.. (2015). Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis. Drug Design Development and Therapy. 9. 3729–3729. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yucheng Xiang Breakdown of academic impact, for papers by Shengsheng Cai Breakdown of academic impact, for papers by Zilin Guan Breakdown of academic impact, for papers by Mahsa Akbari Oryani Breakdown of academic impact, for papers by Linnan Yang Breakdown of academic impact, for papers by Yitian Jiang Breakdown of academic impact, for papers by Lifo Ruan Breakdown of academic impact, for papers by Congjun Xu Breakdown of academic impact, for papers by Junna Lu
Rankless by CCL
2026